• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体-聚阳离子-DNA(LPD)与单磷酰脂质 A(MPL)佐剂制剂在 BALB/c 小鼠模型中的比较。

Comparison of liposome-polycation-DNA(LPD) and monophosphoryl lipid A(MPL) adjuvant formulations in BALB/c mice models.

机构信息

Gansu College of Traditional Chinese Medicine, Lanzhou, Gansu, China.

出版信息

Immunol Invest. 2012;41(4):356-66. doi: 10.3109/08820139.2011.606861. Epub 2011 Aug 24.

DOI:10.3109/08820139.2011.606861
PMID:21864115
Abstract

It is of fundamental importance to use an appropriate adjuvant to generate a potent immune response for immunotherapy. In this study, we had a comparative investigation on the effectiveness of two adjuvant formulations, liposome-polycation-DNA (LPD) and monophosphoryl lipid A(MPL) in combination with a truncated peptide of bFGF(tbFGF) as antigen. LPD/tbFGF induced continuously increasing antibodies expression during the whole immunization period. In contrast, the level of antibodies was variable in MPL/tbFGF-immunized mice, MPL/tbFGF elicited potent antibodies response in the early-phase of immunization (during the first 3 immunizations), but the later immunizations did not produce a significant increase in the level of antibodies. Evaluation of IFN-γ and IL-4 responses revealed that both LPD/tbFGF and MPL/tbFGF demonstrated generation of higher level of IFN-γ, whereas no significant increase in IL-4 levels was detected in the two groups. In addition, histological analysis exhibited obvious germinal centers in the spleen tissues of LPD/tbFGF mice. The data suggested that LPD would be a promising long-effective adjuvant due to its potent and persistent immunostimulation and MPL could play an appropriate role in short-acting immunization.

摘要

使用适当的佐剂来产生有效的免疫应答对于免疫疗法至关重要。在这项研究中,我们比较了两种佐剂制剂——脂质体-聚阳离子-DNA(LPD)和单磷酰脂质 A(MPL)与 bFGF 的截短肽(tbFGF)作为抗原的效果。LPD/tbFGF 在整个免疫期间诱导持续增加的抗体表达。相比之下,MPL/tbFGF 免疫的小鼠的抗体水平是可变的,MPL/tbFGF 在免疫的早期(前 3 次免疫期间)产生了强烈的抗体反应,但随后的免疫没有显著增加抗体水平。IFN-γ 和 IL-4 反应的评估表明,LPD/tbFGF 和 MPL/tbFGF 均产生了更高水平的 IFN-γ,而两组的 IL-4 水平均没有显著增加。此外,组织学分析显示 LPD/tbFGF 小鼠的脾脏组织中存在明显的生发中心。这些数据表明,由于其强大而持久的免疫刺激作用,LPD 将成为一种有前途的长效佐剂,而 MPL 可以在短期免疫中发挥适当的作用。

相似文献

1
Comparison of liposome-polycation-DNA(LPD) and monophosphoryl lipid A(MPL) adjuvant formulations in BALB/c mice models.脂质体-聚阳离子-DNA(LPD)与单磷酰脂质 A(MPL)佐剂制剂在 BALB/c 小鼠模型中的比较。
Immunol Invest. 2012;41(4):356-66. doi: 10.3109/08820139.2011.606861. Epub 2011 Aug 24.
2
Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.含有单磷酰脂质A和QS21的疫苗佐剂系统在健康成年志愿者中诱导出针对乙肝表面抗原的强烈且持久的体液和T细胞应答。
Vaccine. 2008 Mar 4;26(10):1375-86. doi: 10.1016/j.vaccine.2007.12.038. Epub 2008 Jan 14.
3
P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer.P5 HER2/neu 衍生肽与含有 MPL 佐剂的脂质体结合,作为一种有效的乳腺癌预防性疫苗制剂。
Cancer Lett. 2014 Dec 1;355(1):54-60. doi: 10.1016/j.canlet.2014.09.016. Epub 2014 Sep 16.
4
T cell and interferon-gamma involvement in the adjuvant action of a detoxified endotoxin.T细胞和干扰素-γ参与一种解毒内毒素的佐剂作用。
J Biol Response Mod. 1989 Dec;8(6):625-43.
5
The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome.载有可溶性莱什曼抗原(SLA)的纳米脂质体在 BALB/c 小鼠中的免疫作用及 MPL 和咪喹莫特佐剂对其增强作用
Artif Cells Nanomed Biotechnol. 2018;46(sup2):324-333. doi: 10.1080/21691401.2018.1457042. Epub 2018 Apr 1.
6
Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine.检测用脂质体 M2e 流感疫苗免疫后小鼠 Th2 反应的特征。
Vaccine. 2011 Jun 15;29(27):4460-8. doi: 10.1016/j.vaccine.2011.04.040. Epub 2011 May 3.
7
Effect of monophosphoryl lipid A on antibody response to diphtheria toxin and its subunits.单磷酰脂质A对白喉毒素及其亚基抗体反应的影响。
APMIS. 2005 Apr;113(4):256-63. doi: 10.1111/j.1600-0463.2005.apm_03.x.
8
Synergistic effects between Staphylococcal enterotoxin type B and Monophosphoryl lipid A against mouse fibrosarcoma.B型葡萄球菌肠毒素与单磷酰脂质A对小鼠纤维肉瘤的协同作用。
J BUON. 2010 Apr-Jun;15(2):340-7.
9
Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.评估单磷酰脂质A(MPL)佐剂配制的重组致密颗粒抗原GRA2和GRA6对小鼠弓形虫慢性感染的保护作用。
Vaccine. 2007 May 22;25(21):4301-11. doi: 10.1016/j.vaccine.2007.02.057. Epub 2007 Mar 9.
10
Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines.用于下一代疫苗的单磷酰脂质A(MPL)制剂。
Methods. 1999 Sep;19(1):103-7. doi: 10.1006/meth.1999.0834.